透视引导提高胸段硬膜外导管置入硬膜外腔的发生率:一项随机试验
这项随机试验将100例胸科手术患者分为透视引导组(n=47)和阻力消失法(盐水/空气)组(n=53),发现透视引导组导管位于硬膜外腔的比例为98%(46/47),显著高于阻力消失组的74%(39/53)。两组24小时吗啡用量和疼痛评分无差异,但校正分析中正确置管与更短PACU停留和总住院时间相关。
要点
- 透视引导使胸段硬膜外导管正确置入硬膜外腔的比例从74%提升至98%。
- 透视引导未改善24小时吗啡用量或疼痛评分。
- 正确置管与更短PACU停留和总住院时间相关。
核心结论
- 透视引导增加胸段硬膜外导管置入硬膜外腔的发生率,并可能缩短PACU和住院时间。
研究设计与样本
- 随机临床试验,在Dartmouth-Hitchcock医学中心历时25个月(2012年1月至2014年2月)进行,100例胸科手术患者随机分为透视引导组(n=47)和阻力消失法(盐水/空气)组(n=53),按意向治疗分析。
主要发现
- 透视引导组98%(46/47)导管位于硬膜外腔,阻力消失组为74%(39/53)。
- 两组24小时数字疼痛评分和24小时吗啡用量无差异。
- 校正混杂变量后,正确置管的比值比(OR)为21.07(95%CI 2.07-214.38,P=0.010);未校正时为16.15(95%CI 2.03-128.47,P=0.009)。
- 校正分析中,正确置管的胸段硬膜外导管与更短PACU停留(5.87±5.39小时 vs 4.30±1.171小时,P=0.044)和总住院时间(5.77±4.94天 vs 4.93±2.79天,P=0.031)相关。
临床怎么用
- 对于胸科手术患者,可考虑使用透视引导置入胸段硬膜外导管以提高硬膜外腔置管成功率。
局限性
- 研究结论需未来工作验证该方法的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Thoracic epidural analgesia can reduce postoperative pain and cardiopulmonary morbidity, but it is associated with a high rate of clinical failure. Up to 50% of clinical failure is thought to be related to technical insertion. In this study, patients undergoing thoracic surgery were randomized to one of two catheter insertion techniques: fluoroscopically guided or conventional loss of resistance with saline/air. Our primary aim was to examine whether fluoroscopic guidance could increase the incidence of correct catheter placement and improve postoperative analgesia. Our secondary aim was to assess the potential impact of correct epidural catheter positioning on length of stay in the postanesthesia care unit and total hospital length of stay. METHODS: This randomized clinical trial was conducted at Dartmouth-Hitchcock Medical Center over 25 months (January 2012 to February 2014). Patients (N = 100) undergoing thoracic surgery were randomized to fluoroscopic guidance (n = 47) or to loss of resistance with saline/air (n = 53). Patients were followed for the primary outcomes of 24-hour morphine use, 24-hour numeric pain scores, and the incidence of epidural catheter positioning within the epidural space. Postanesthesia care unit and total hospital lengths of stay were evaluated as secondary outcome measurements and compared for patients with correct epidural catheter positioning and those without correct epidural catheter positioning. RESULTS: One hundred patients were included in an intention-to-treat analysis. Numeric pain scores and 24-hour morphine consumption were no different between groups. Fluoroscopic guidance was associated with an increased incidence of epidural catheter placement within the epidural space compared with loss of resistance with air/saline [fluoroscopic guidance, epidural in 98% (46/47) versus loss of resistance with saline/air, epidural in 74% (39/53)]. There was a significant increase in correct catheter positioning with (odds ratio, 21.07; 95% confidence interval, 2.07-214.38; P = 0.010) or without (odds ratio, 16.15; 95% confidence interval, 2.03-128.47; P = 0.009) adjustment for potentially confounding variables. In an adjusted analysis, correctly positioned thoracic epidural catheters were associated with shorter postanesthesia care unit (5.87 ± 5.39 hours vs 4.30 ± 1.171 hours; P = 0.044) and total hospital length of stay (5.77 ± 4.94 days vs 4.93 ± 2.79 days; P = 0.031). CONCLUSIONS: Fluoroscopic guidance increases the incidence of epidural catheter positioning within the epidural space and may reduce postanesthesia care unit and hospital lengths of stay. Future work should validate the effectiveness of this approach.This clinical trial is registered with ClinicalTrials.gov (NCT02678039).
引用
- Parra MC, Washburn K, Brown JR, et al. Fluoroscopic Guidance Increases the Incidence of Thoracic Epidural Catheter Placement Within the Epidural Space: A Randomized Trial. Reg Anesth Pain Med. 2017. PMID: 27922948. doi:10.1097/AAP.0000000000000519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。